Earnings History Data for Reneo Pharmaceuticals, Inc. (RPHM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals Inc.is a clinical stage pharmaceutical company. It is focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases. Reneo Pharmaceuticals Inc.is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-08-2024 | PM | RPHM | Reneo Pharmaceuticals | 45.00 | -0.16 | -0.17 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.16 [8/13/2024 9:10 AM] |
1.38 | 0.04 (2.99%) |
1.36 | 0.02 (1.49%) |
0.98 - 9.21 | 266,102 | 60,000 | 303 | ||
| 07-05-2024 | PM | RPHM | Reneo Pharmaceuticals | 58.00 | -0.25 | -0.37 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.25 [5/7/2024 8:02 AM] |
1.76 | 0.03 (1.73%) |
1.79 | 0.06 (3.47%) |
0.98 - 9.93 | 100,946 | 100,000 | 983 | ||
| 28-03-2024 | PM | RPHM | Reneo Pharmaceuticals | 55.00 | -0.70 | -0.55 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$2.52 [3/28/2024 3:13 PM] |
1.65 | 0.0 (0.00%) |
1.65 | 0.0 (0.00%) |
0.98 - 11.30 | 89,889 | 170,000 | 2,004 | ||
| 13-11-2023 | PM | RPHM | Reneo Pharmaceuticals | 218.00 | -0.57 | -0.60 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.57 [11/13/2023 8:49 AM] |
6.25 | -0.15 (-2.27%) |
0.0 | 0.0 (0.00%) |
1.79 - 11.30 | 161,235 | 180,000 | 0 | ||
| 10-08-2023 | PM | RPHM | Reneo Pharmaceuticals | 230.00 | -0.65 | -0.55 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.65 misses by $0.13 [8/10/2023 12:12 PM] |
6.53 | -0.11 (-1.73%) |
6.65 | 0.01 (0.15%) |
1.79 - 11.30 | 111,241 | 170,000 | 414 | ||
| 11-05-2023 | PM | RPHM | Reneo Pharmaceuticals | 210.00 | -0.60 | -0.63 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.60 in-line [5/11/2023 9:54 AM] |
8.54 | 0.56 (7.02%) |
8.35 | 0.37 (4.64%) |
1.79 - 11.30 | 134,801 | 210,000 | 3,560 | ||
| 27-03-2023 | PM | RPHM | Reneo Pharmaceuticals | 137.00 | -0.56 | -0.62 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.56 [3/27/2023 9:38 AM] |
5.90 | -0.14 (-2.32%) |
6.04 | 0.0 (0.00%) |
1.79 - 6.71 | 42,365 | 60,000 | 312 | ||
| 08-11-2022 | PM | RPHM | Reneo Pharmaceuticals | 70.00 | -0.53 | -0.58 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.53 [11/8/2022 9:22 AM] |
2.96 | -0.08 (-2.70%) |
0.0 | 0.0 (0.00%) |
1.92 - 10.00 | 12,704 | 20,000 | 0 | ||
| 09-08-2022 | PM | 0:00 AM ET (Aug 9) |
RPHM | Reneo Pharmaceuticals | 65.00 | -0.50 | -0.60 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08 [8/9/2022 8:36 AM] |
2.53 | -0.13 (-4.89%) |
2.89 | 0.23 (8.65%) |
1.92 - 11.40 | 50,716 | 130,000 | 1,152 | |
| 10-05-2022 | AH | RPHM | Reneo Pharmaceuticals | 55.00 | -0.53 | -0.54 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.53 misses by $0.01 [5/10/2022 5:51 PM] |
2.37 | -0.03 (-1.25%) |
2.40 | 0.0 (0.00%) |
2.03 - 13.75 | 144,458 | 80,000 | 2,578 | ||
| 23-03-2022 | AH | RPHM | Reneo Pharmaceuticals | 87.00 | -0.43 | -0.59 | 0.00 | Reneo Pharmaceuticals GAAP EPS of -$0.43 beats by $0.14 [3/23/2022 5:35 PM] |
3.48 | -0.09 (-2.52%) |
3.57 | 0.0 (0.00%) |
3.31 - 17.18 | 40,165 | 42,206 | 165 | ||
| 11-11-2021 | AH | 5:55 AM ET (Nov 12) |
RPHM | Reneo Pharmaceuticals, Inc. | 193.53 | -0.52 | -0.47 | 0.00 | Reneo Pharmaceuticals EPS misses by $0.05 [11/11/2021 4:23 PM] |
8.74 | 0.33 (3.92%) |
8.88 | 0.47 (5.59%) |
6.10 - 17.18 | 20,049 | 30,000 | 2,294 | |
| 11-08-2021 | PM | RPHM | Reneo Pharmaceuticals, Inc. | 201.00 | -0.43 | -0.37 | 0.00 | Reneo Pharmaceuticals EPS misses by $0.05 [8/11/2021 6:21 AM] |
8.50 | 0.01 (0.12%) |
0.0 | 0.0 (0.00%) |
7.63 - 17.18 | 10,266 | 10,000 | 0 | ||